vs
Side-by-side financial comparison of ICU MEDICAL INC (ICUI) and Stevanato Group S.p.A. (STVN). Click either name above to swap in a different company.
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, a...
Stevanato Group is an Italian multinational company headquartered in Piombino Dese, Padua – Italy. Founded in 1949, it is also active in the glass tube forming technology and inspection systems sector.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $540.7M | — | ||
| Q3 25 | $537.0M | — | ||
| Q2 25 | $548.9M | — | ||
| Q1 25 | $604.7M | — | ||
| Q4 24 | $629.8M | — | ||
| Q3 24 | $589.1M | — | ||
| Q2 24 | $596.5M | — | ||
| Q1 24 | $566.7M | — |
| Q4 25 | $-15.7M | — | ||
| Q3 25 | $-3.4M | — | ||
| Q2 25 | $35.3M | — | ||
| Q1 25 | $-15.5M | — | ||
| Q4 24 | $-23.8M | — | ||
| Q3 24 | $-33.0M | — | ||
| Q2 24 | $-21.4M | — | ||
| Q1 24 | $-39.5M | — |
| Q4 25 | 37.5% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | 37.9% | — | ||
| Q1 25 | 34.7% | — | ||
| Q4 24 | 36.1% | — | ||
| Q3 24 | 34.8% | — | ||
| Q2 24 | 34.8% | — | ||
| Q1 24 | 32.7% | — |
| Q4 25 | 1.0% | — | ||
| Q3 25 | 2.6% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | -1.9% | — |
| Q4 25 | -2.9% | — | ||
| Q3 25 | -0.6% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | -2.6% | — | ||
| Q4 24 | -3.8% | — | ||
| Q3 24 | -5.6% | — | ||
| Q2 24 | -3.6% | — | ||
| Q1 24 | -7.0% | — |
| Q4 25 | $-0.63 | — | ||
| Q3 25 | $-0.14 | — | ||
| Q2 25 | $1.43 | — | ||
| Q1 25 | $-0.63 | — | ||
| Q4 24 | $-0.97 | — | ||
| Q3 24 | $-1.35 | — | ||
| Q2 24 | $-0.88 | — | ||
| Q1 24 | $-1.63 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
